Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 6, 2018
October 18, 2019
7d286113-df13-47f4-bc30-1a4d819e56c9
Related Documents
Labeling for Biosimilar and Interchangeable Biosimilar Products
Guidance DocumentSeptember 18, 2023Center for Drug Evaluation and Research
Drug Abuse and Dependence Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry
Guidance DocumentJuly 1, 2019Center for Drug Evaluation and Research
Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products — Content and Format
Guidance DocumentJanuary 12, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox